McBride John S.
Insider CIK 1618251 · TKAI Chief Operating Officer, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ELDN Eledon Pharmaceuticals, In | M Exercise deriv | 2026-01-10 | 2026-01-16 | 3,430 | — | $0 | 0 | SEC↗ |
| ELDN Eledon Pharmaceuticals, In | M Exercise | 2026-01-10 | 2026-01-16 | 3,430 | — | $0 | 3,430 | SEC↗ |
| ELDN Eledon Pharmaceuticals, In | A Award deriv | 2025-01-10 | 2025-01-13 | 30,870 | — | $0 | 30,870 | SEC↗ |
| ELDN Eledon Pharmaceuticals, In | A Award deriv | 2025-01-10 | 2025-01-13 | 3,430 | — | $0 | 3,430 | SEC↗ |
| ELDN Eledon Pharmaceuticals, In | A Award deriv | 2023-05-01 | 2023-05-02 | 150,437 | — | $0 | 150,437 | SEC↗ |
| ELDN Eledon Pharmaceuticals, In | A Award deriv | 2023-02-01 | 2023-02-02 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ELDN Eledon Pharmaceuticals, In | A Award deriv | 2022-02-01 | 2022-02-02 | 20,000 | — | $0 | 20,000 | SEC↗ |
| NVUS Novus Therapeutics, Inc. | A Award deriv | 2020-09-11 | 2020-09-15 | 1,167 | — | $0 | 1,167 | SEC↗ |
| NVUS Novus Therapeutics, Inc. | A Award deriv | 2019-07-11 | 2019-07-15 | 20,000 | — | $0 | 20,000 | SEC↗ |
| NVUS Novus Therapeutics, Inc. | A Award deriv | 2018-06-13 | 2018-06-14 | 9,100 | — | $0 | 9,100 | SEC↗ |
| NVUS Novus Therapeutics, Inc. | A Award deriv | 2017-06-30 | 2017-07-05 | 18,000 | — | $0 | 18,000 | SEC↗ |
| TKAI Tokai Pharmaceuticals Inc | A Award deriv | 2015-12-15 | 2015-12-17 | 62,000 | — | $0 | 62,000 | SEC↗ |
| TKAI Tokai Pharmaceuticals Inc | M Exercise deriv | 2015-09-21 | 2015-09-22 | 13,500 | — | $0 | 186,678 | SEC↗ |
| TKAI Tokai Pharmaceuticals Inc | M Exercise | 2015-09-21 | 2015-09-22 | 13,500 | $4.19 | $56.6K | 13,500 | SEC↗ |
| TKAI Tokai Pharmaceuticals Inc | S Sale | 2015-09-21 | 2015-09-22 | 13,500 | $14.01 | $189.1K | 0 | SEC↗ |
| TKAI Tokai Pharmaceuticals Inc | M Exercise deriv | 2015-06-24 | 2015-06-24 | 300 | — | $0 | 200,178 | SEC↗ |
| TKAI Tokai Pharmaceuticals Inc | S Sale | 2015-06-24 | 2015-06-24 | 300 | $14.20 | $4.3K | 0 | SEC↗ |
| TKAI Tokai Pharmaceuticals Inc | M Exercise | 2015-06-24 | 2015-06-24 | 300 | $4.19 | $1.3K | 300 | SEC↗ |
| TKAI Tokai Pharmaceuticals Inc | M Exercise deriv | 2015-06-23 | 2015-06-24 | 6,700 | — | $0 | 200,478 | SEC↗ |
| TKAI Tokai Pharmaceuticals Inc | S Sale | 2015-06-23 | 2015-06-24 | 6,700 | $14.00 | $93.8K | 0 | SEC↗ |
| TKAI Tokai Pharmaceuticals Inc | M Exercise | 2015-06-23 | 2015-06-24 | 6,700 | $4.19 | $28.1K | 6,700 | SEC↗ |
| TKAI Tokai Pharmaceuticals Inc | M Exercise deriv | 2015-06-22 | 2015-06-24 | 2,000 | — | $0 | 207,178 | SEC↗ |
| TKAI Tokai Pharmaceuticals Inc | M Exercise | 2015-06-22 | 2015-06-24 | 2,000 | $4.19 | $8.4K | 2,000 | SEC↗ |
| TKAI Tokai Pharmaceuticals Inc | S Sale | 2015-06-22 | 2015-06-24 | 2,000 | $14.02 | $28.0K | 0 | SEC↗ |
| TKAI Tokai Pharmaceuticals Inc | A Award deriv | 2014-10-15 | 2014-10-17 | 50,671 | — | $0 | 50,671 | SEC↗ |